The DOI matches its Crossref record; 0 of the 1 references it cites were found in a registry or an index.
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Abstract
Bacterial infection of the mammalian bloodstream can lead to overwhelming sepsis, a potentially fatal syndrome of irreversible cardiovascular collapse (shock) and critical organ failure. Cachectin, also known as tumour necrosis factor, is a macrophage-derived peptide hormone released in response to bacterial lipopolysaccharide, and it has been implicated as a principal mediator of endotoxic shock, although its function in bacterial sepsis is not known. Anaesthetized baboons were passively immunized against endogenous cachectin and subsequently infused with an LD100 dose of live Escherichia coli. Control animals (not immunized against cachectin) developed hypotension followed by lethal renal and pulmonary failure. Neutralizing monoclonal anti-cachectin antibody fragments (F(ab')2) administered to baboons only one hour before bacterial challenge protected against shock, but did not prevent critical organ failure. Complete protection against shock, vital organ dysfunction, persistent stress hormone release and death was conferred by administration of antibodies 2 h before bacterial infusion. These results indicate that cachectin is a mediator of fatal bacteraemic shock, and suggest that antibodies against cachectin offer a potential therapy of life-threatening infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TNF is produced during Gram-negative bacteria-induced acute septic shock (3).”
From Physiology and immunology of the cholinergic antiinflammatory pathway (2007) · cites this paper as [3]
In the citing paper
“Consider as one example the case of TNF, a cytokine implicated as a necessary and sufficient mediator of lethal septic shock caused by infection with Gram-negative bacteria.”
From Physiology and immunology of the cholinergic antiinflammatory pathway (2007) · cites this paper as [3]
Citations
Cites
1. Kreger, B. E. W., Craven, D. E. & McCabe, W. R. Am. J. Med. 68, 344-355 (1980). 2. Ziegler, E. J. el al New Engl. J. Med, 307, 1225-1230 (1982). 3. Gilbert, R. P. Physiol. Rev. 40, 245-279 (1960). 4. Beutler, B. & Cerami, A. Nature 320, 584-588 (1986). 5. Beutler, B. & Cerami, A. New Engl. J. Med
(n.d.)
Unresolved
Cited by
Sorted by citations
Items 501–600 of 1,001
Cross, A. S., Asher, L. V. S., Seguin, M. C., Yuan, L., Kelly, N. M., Hammack, C., SADOFF, J. C., & Gemski, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118110 · Cited by 117
“to produce detrimental results as observed both experimentally (39, 40) and in recent clinical trials with IL-1 receptor antagonist and anti-TNF mAb(41 ) where there was increased mortality in the treatment compared to the placebo group; however, in animals (40, 42, 43) and patients whose LPSinitiated pathways have al…”
ResultKwon, O., Molitoris, B. A., Pescovitz, M. D., & Kelly, K. J. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00206-3 · Cited by 116
Tumor necrosis factor activities and cancer therapy — A perspective
Sidhu, R. S., & Bollon, A. P. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90037-e · Cited by 114
Heslop, H., Gottlieb, D. J., Bianchi, A., et al. (1989) · Blood · doi:10.1182/blood.v74.4.1374.1374 · Cited by 117
Peña, G., Cai, B., Liu, J., van der Zanden, E. P., Deitch, E. A., de Jonge, W. J., & Ulloa, L. (2010) · European Journal of Immunology · doi:10.1002/eji.201040540 · Cited by 116
Greve, J. W. M., Gouma, D. J., Soeters, P. B., et al. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90841-n · Cited by 116
Teti, G., Mancuso, G., & Tomasello, F. F. (1993) · Infection and Immunity · doi:10.1128/iai.61.1.227-235.1993 · Cited by 116
“04) 13 ± 3 (14) 35 ± 15 (45) 36 ± 11 (38) 32 ± 16 (40)”
BackgroundInfluentialStrieter, R. M., Kunkel, S. L., Keane, M. P., & Standiford, T. J. (1999) · CHEST Journal · doi:10.1378/chest.116.suppl_1.103s · Cited by 115
Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression
Yao, L., Bengualid, V., Lowy, F. D., et al. (1995) · Infection and Immunity · doi:10.1128/iai.63.5.1835-1839.1995 · Cited by 116
“In humans, IL-1 and IL-6 levels correlated with disease severity (6–8, 12), and antibodies to these cytokines reduced mortality in experimental animal models of sepsis caused by infections with gram-negative organisms (11, 24, 34).”
BackgroundThe Horror Autotoxicus and Multiple-Organ Failure
Baue, A. E. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420120085016 · Cited by 116
Models of the pathogenesis of necrotizing enterocolitis
Kliegman, R. M. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81123-0 · Cited by 112
Elevated serum levels of tumor necrosis factor‐α in Guillain‐Barré syndrome
Sharief, M. K., McLean, B., & Thompson, E. J. (1993) · Annals of Neurology · doi:10.1002/ana.410330606 · Cited by 116
A tumor necrosis factor binding protein is present in human biological fluids
Peetre, C., Thysell, H., GRUBB, A. O., & Olsson, I. (1988) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1988.tb00220.x · Cited by 115
Anti–tumor necrosis factor-α therapy in uveitis
Cordero‐Coma, M., & Sobrin, L. (2015) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2015.06.004 · Cited by 114
Aderka, D., Sorkine, P., Abu-Abid, S., Lev, D. C., Setton, A., Cope, A. P., Wallach, D., & Klausner, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci694 · Cited by 115
Norman, J. G., Fink, G. W., Messina, J. L., Carter, G., & Franz, M. (1996) · Surgery · doi:10.1016/s0039-6060(96)80072-9 · Cited by 115
Heat stress increases survival rates in lipopolysaccharide-stimulated rats
Chu, E., Ribeiro, S. P., & Slutsky, A. S. (1997) · Critical Care Medicine · doi:10.1097/00003246-199710000-00025 · Cited by 111
The Metabolic Basis of Immune Dysfunction Following Sepsis and Trauma
McBride, M. A., Owen, A. M., Stothers, C. L., Hernandez, A., Luan, L., Burelbach, K. R., Patil, T. K., Bohannon, J. K., Sherwood, E. R., & Patil, N. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01043 · Cited by 120
“Blockade of pro-inflammatory mediators in experimental animals attenuated or prevented the development of septic shock (6, 7).”
BackgroundTreede, I., Braun, A., Jeliaskova, P., Giese, T., Füllekrug, J., Griffiths, G. W., Stremmel, W., & Ehehalt, R. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-53 · Cited by 111
“Interestingly, there is a sudden overproduction of TNF-α in acute septic shock which triggers hypotension, circulatory collapse, and the widespread inflammation seen in this clinical condition [43].”
BackgroundCytokine modulation in sepsis and septic shock
Zanotti, S. L., Kumar, A., & Kumar, A. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.8.1061 · Cited by 116
“When given prior to challenge, antibodies to TNF-α protect mice and rabbits from endotoxic shock as well as protecting baboons from a lethal parenteral infusion of Escherichia coli [31-33].”
BackgroundKristensen, C. A., Nozue, M., Boucher, Y., & Jain, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.397 · Cited by 113
A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis
Kang, R., Zeng, L., Xie, Y., Yan, Z., Zhou, B., Cao, L., Klionsky, D. J., Tracey, K. J., Li, J., Wang, H., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1239678 · Cited by 110
Self-citationMiksa, M., Wu, R., Dong, W., Komura, H., Amin, D., Ji, Y., Wang, Z., Wang, H., Ravikumar, T. S., Tracey, K. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802994 · Cited by 111
“Studies using inhibitors of these cytokines demonstrated increased survival of septic mice treated with TNF- or HMGB1 blocking Abs (8, 22).”
BackgroundSelf-citationNEUTRALIZATION OF TUMOR NECROSIS FACTOR IN PRECLINICAL MODELS OF SEPSIS
Lorente, J. A., & Marshall, J. C. (2005) · Shock · doi:10.1097/01.shk.0000191343.21228.78 · Cited by 112
“On the other hand, work in mice and baboons has failed to show usefulness when therapeutic intervention is delayed (35, 37, 114).”
BackgroundBohatschek, M., Werner, A., & Raivich, G. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7764 · Cited by 112
Superantigen and endotoxin synergize in the induction of lethal shock
Blank, C. A., Luz, A., Bendigs, S., Erdmann, A. A., Wagner, H., & Heeg, K. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270405 · Cited by 111
Regulation of the Expression of the Inducible Isoform of Nitric Oxide Synthase
Szabó, C., & Thiemermann, C. (1995) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61083-2 · Cited by 111
Clinical trials of mediator-directed therapy in sepsis: what have we learned?
Marshall, J. C. (2000) · Intensive Care Medicine · doi:10.1007/s001340051122 · Cited by 113
“and activity was central to the lethality of endotoxemia and microbial infection, including cytokines such as tumor necrosis factor (TNF) [ 3 ] and interleukin 1 (IL-1) [4], prostaglandins [5], and nitric oxide [6].”
BackgroundTherapeutic potential of HMGB1-targeting agents in sepsis
Wang, H., Zhu, S., Zhou, R., Li, W., & Sama, A. E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000884 · Cited by 115
“17), prompting a search for other, late pro-inflammatory mediators that may offer a wider therapeutic window.”
Richter, A., Listing, J., Schneider, M., Klopsch, T., Kapelle, A., Kaufmann, J., Zink, A., & Strangfeld, A. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207838 · Cited by 113
Spittler, A., Reissner, C. M., Oehler, R., Gornikiewicz, A., Gruenberger, T., Manhart, N., Brodowicz, T., Mittlboeck, M., Boltz‐Nitulescu, G., & Roth, E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.3.563 · Cited by 112
“Administration of IL-10 in animal models has been shown to protect against the lethal endotoxemia, and treatment with anti-TNF monoclonal antibodies (mAb’s) prevent septic shock (13, 14 ).”
BackgroundMabie, W. C. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00352-9 · Cited by 111
Attal, M., Huguet, F., Rubie, H., et al. (1993) · Blood · doi:10.1182/blood.v82.3.732.732 · Cited by 111
Enhanced production of bovine tumor necrosis factor-α during the periparturient period
Sordillo, L. M., Pighetti, G. M., & Davis, M. R. (1995) · Veterinary Immunology and Immunopathology · doi:10.1016/0165-2427(95)05465-0 · Cited by 110
Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide
Kumar, A., Krieger, A. C., Symeoneides, S., Kumar, A., & Parrillo, J. E. (2001) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/jcan.2001.25003 · Cited by 110
Gram-Negative Sepsis and the Adult Respiratory Distress Syndrome
Martin, M. A., & Silverman, H. J. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.6.1213 · Cited by 109
Yumoto, M., Nishida, O., Moriyama, K., et al. (2011) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2011.00971.x · Cited by 109
“difficult therapeutic target in clinical settings (3).”
Yeo, S.-J., Yoon, J.-G., Hong, S., & Yi, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.1052 · Cited by 107
Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers
Zhu, S., Ashok, M., Li, J., Li, W., Yang, H., Wang, P., Tracey, K. J., Sama, A. E., & Wang, H. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00062 · Cited by 109
“In animal models of lethal systemic inflammation, TNF (13), IL-1 (14), interferon (IFN)-γ (15), macrophage migration inhibitory factor (MIF) (16,17), and HMGB1 (5,18), individually or in combination, contribute to the pathogenesis of diseases.”
Self-citationAndersson, U., & Tracey, K. J. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310016286 · Cited by 108
“This time-frame represents a significant shift away from the early proinflammatory cytokines, such as interleukin-1 (IL-1) and TNF, which are produced in the first few minutes or hours after exposure to endotoxin (13).”
BackgroundSelf-citationUnderstanding the role of inflammatory cytokines in malaria and related diseases
Clark, I. A., Alleva, L. M., Budd, A. C., & Cowden, W. B. (2007) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2007.07.002 · Cited by 110
Delgado, M., & Ganea, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31930 · Cited by 107
Steinshamn, S., & Waage, A. (1992) · Infection and Immunity · doi:10.1128/iai.60.10.4003-4008.1992 · Cited by 108
“High levels of TNF have been correlated with a fatal outcome in human meningococcal septicemia (37), and there is firm experimental evidence that TNF is a mediator in septic shock (30, 31).”
BackgroundCardiac dysfunction in sepsis: new theories and clinical implications
Grocott-Mason, R. M., & Shah, A. M. (1998) · Intensive Care Medicine · doi:10.1007/s001340050570 · Cited by 103
“Exposure of animals to live bacteria induces septic shock, which can be prevented by pretreatment with anti-TNFa antibodies [ 31 ].”
BackgroundBocci, V. A. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199121040-00004 · Cited by 105
Pathophysiologic basis of sepsis: Considerations for future strategies of intervention
Glauser, M. P. (2000) · Critical Care Medicine · doi:10.1097/00003246-200009001-00002 · Cited by 103
New approaches to the study of sepsis
Ward, P. A. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201375 · Cited by 110
HMGB1 modulates inflammatory responses in LPS-activated macrophages
Gazzar, M. E. (2007) · Inflammation Research · doi:10.1007/s00011-006-6112-0 · Cited by 106
“injury, infl ammation, and endotoxic shock [6, 17 ].”
BackgroundMechanisms and Mediators of the Adult Respiratory Distress Syndrome
Rinaldo, J. E., & Christman, J. W. (1990) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)00759-0 · Cited by 103
Tumour necrosis factor: a cytokine with multiple biological activities
Semenzato, G. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.78 · Cited by 105
Liu, Y., Shi, W., Zhou, E., et al. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00517-09 · Cited by 105
“Antibodies against TNF- can help infected animals fight against the septic shock caused by the bacterium (21).”
BackgroundRibeiro, S. P., Villar, J., Downey, G. P., et al. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.6.8970379 · Cited by 105
A Critical Evaluation of New Agents for the Treatment of Sepsis
Bone, R. C. (1991) · JAMA · doi:10.1001/jama.1991.03470120088038 · Cited by 109
Ishii, Y., Partridge, C. A., Vecchio, P. J. D., & Malik, A. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115658 · Cited by 104
“Tumor necrosis factor-a (TNFa)' is an important mediator of endotoxic shock and the associated high permeability pulmonary edema (1, 2).”
BackgroundRole of the adaptive immune response in sepsis
Brady, J., Horie, S., & Laffey, J. G. (2020) · Intensive Care Medicine Experimental · doi:10.1186/s40635-020-00309-z · Cited by 109
Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung.
Strieter, R. M., Lukacs, N. W., Standiford, T. J., & Kunkel, S. L. (1993) · Thorax · doi:10.1136/thx.48.7.765 · Cited by 102
Töllner, B., Roth, J., Störr, B., Martin, D., Voigt, K., & Zeisberger, E. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000386 · Cited by 103
Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide
McGown, C. C., & Brookes, Z. L. S. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/ael358 · Cited by 102
Mechanisms of acute inflammatory lung injury induced by abdominal sepsis
Neumann, B., Zantl, N., Veihelmann, A., Emmanuilidis, K., Pfeffer, K., Heidecke, C., & Holzmann, B. (1999) · International Immunology · doi:10.1093/intimm/11.2.217 · Cited by 102
Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression
Zuckerman, S. H., Evans, G. F., & Butler, L. D. (1991) · Infection and Immunity · doi:10.1128/iai.59.8.2774-2780.1991 · Cited by 101
“coli-infused baboons (11, 37) and in endotoxin-stimulated mice (46).”
BackgroundTureen, J. H. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117755 · Cited by 103
Biologic Control of Injury and Inflammation: Much More than Too Little or Too Late
Guirao, X., & Lowry, S. F. (1996) · World Journal of Surgery · doi:10.1007/s002689900069 · Cited by 102
Self-citationKim, H. G., Lee, S. Y., Kim, N. R., Lee, H. Y., Ko, M. Y., Jung, B. J., Kim, C. M., Lee, J. M., Park, J. H., Han, S. H., et al. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.07.011 · Cited by 103
Inflammatory Cytokines and Lipopolysaccharide Induce Fas-Mediated Apoptosis in Renal Tubular Cells
Jo, S., Cha, D. R., Cho, W. Y., Kim, H. K., Chang, K. H., Yun, S. Y., & Won, N. H. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000064280 · Cited by 102
Lipopolysaccharide-Induced Fetal Death: The Role of Tumor-Necrosis Factor Alpha1
Silver, R. M., Lohner, W. S., Daynes, R. A., Mitchell, M. D., & Branch, D. W. (1994) · Biology of Reproduction · doi:10.1095/biolreprod50.5.1108 · Cited by 100
Tumor Necrosis Factor-α Mediates Acid Aspiration-induced Systemic Organ Injury
Goldman, G., Welbourn, R., Kobzik, L., VALERI, C. R., Sheṕro, D., & Hechtman, H. B. (1990) · Annals of Surgery · doi:10.1097/00000658-199010000-00013 · Cited by 101
Gadina, M., Bertini, R., Mengozzi, M., et al. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.6.1305 · Cited by 102
Immunologic Therapy for ARDS, Septic Shock, and Multiple-Organ Failure
John, R. C. S., & Dorinsky, P. (1993) · CHEST Journal · doi:10.1378/chest.103.3.932 · Cited by 100
Groote, M. A. D. (1989) · JAMA · doi:10.1001/jama.262.2.249 · Cited by 102
Hevia, H., Varela‐Rey, M., Corrales, F. J., Berasain, C., Martínez‐Chantar, M. L., Latasa, M. U., Lu, S. C.-L., Mato, J. M., García–Trevijano, E. R., & Avila, M. A. (2004) · Hepatology · doi:10.1002/hep.20154 · Cited by 99
Macrophage migration inhibitory factor: Cytokine, hormone, or enzyme?
Swope, M. D., & Lolis, E. (2005) · Springer eBooks · doi:10.1007/bfb0033647 · Cited by 100
“Co-injection of antibodies or antagonists of these sepsismediating cytokines protects mice from LPS-induced lethality ( Tracey et al. 1987; McNamara et al. 1993).”
BackgroundDysregulation of the angiopoietin–Tie-2 axis in sepsis and ARDS
Parikh, S. M. (2013) · Virulence · doi:10.4161/viru.24906 · Cited by 103
Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis
Remick, D. G., Garg, S. J., Newcomb, D. E., Wollenberg, G. K., Huie, T., & Bolgos, G. L. (1998) · Critical Care Medicine · doi:10.1097/00003246-199805000-00025 · Cited by 100
van Helden, H. P. M., Kuijpers, W. C., Steenvoorden, D., Go, C., Bruijnzeel, P. L. B., van Eijk, M., & Haagsman, H. P. (1997) · Experimental Lung Research · doi:10.3109/01902149709039228 · Cited by 100
Meldrum, D. R., & DONNAHOO, K. K. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5660 · Cited by 99
Blok, W. L., Vogels, M. T. E., Curfs, J. H. A. J., Eling, W. M. C., Buurman, W. A., & van der Meer, J. W. M. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/165.5.898 · Cited by 103
“Antibodies to TNF have prevented death in experimental gram-negative infection and in experimental cerebral malaria [15, 16].”
BackgroundIsumi, Y., Minamino, N., Katafuchi, T., Yoshioka, M., Tsuji, T., Kangawa, K., & Matsuo, H. (1998) · Endocrinology · doi:10.1210/endo.139.5.6004 · Cited by 101
Anti-Inflammatory Effects of Hyperoside in Human Endothelial Cells and in Mice
Ku, S., Zhou, W. P., Lee, W., Han, M. S., Na, M., & Bae, J. (2014) · Inflammation · doi:10.1007/s10753-014-9989-8 · Cited by 101
“Ninety six-well plastic flat microtiter plates (Corning) were coated with sEPCR or TNF-α converting enzyme (TACE) protein in 20 mM carbonate-bicarbonate buffer (pH 9.6) containing 0.02 % sodium azide overnight at 4 °C. Lyophilized culture media were prepared for sEPCR, and total cell lysates were prepared for TACE usi…”
InfluentialA pairwise cytokine code explains the organism-wide response to sepsis
Takahama, M., Patil, A., Johnson, K., Cipurko, D., Miki, Y., Taketomi, Y., Carbonetto, P. S., Plaster, M., Richey, G., Pandey, S., et al. (2024) · Nature Immunology · doi:10.1038/s41590-023-01722-8 · Cited by 110
“TNF antibodies protect against lethal sepsis when present before or early on upon the start of the disease 52,53 , but not later in the disease, which helps to explain the failure of anti-TNF therapy in humans with sepsis 2,54 .”
Olas, K., Butterweck, H. A., Teschner, W., Schwarz, H. P., & Reipert, B. M. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02779.x · Cited by 99
Plasma tumour necrosis factor alpha in cystic fibrosis.
Norman, D., Elborn, J. S., Cordon, S. M., Rayner, R. J., Wiseman, M., Hiller, E., & Shale, D. J. (1991) · Thorax · doi:10.1136/thx.46.2.91 · Cited by 99
Tomofuji, T., Ekuni, D., Yamanaka, R., Kusano, H., Azuma, T., Sanbe, T., Tamaki, N., Yamamoto, T., Watanabe, T., Miyauchi, M., et al. (2007) · Journal of Periodontology · doi:10.1902/jop.2007.070056 · Cited by 99
The pathophysiology of advanced heart failure
Baig, M. K., Mahon, N., McKenna, W. J., Caforio, A. L. P., Bonow, R. O., Francis, G. S., & Gheorghiade, M. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70252-2 · Cited by 97
Crespo, A., Filla, M. B., Russell, S. W., & MURPHY, W. J. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490099 · Cited by 103
Granowitz, E. V., Vannier, E. G., Poutsiaka, D., & Dinarello, C. A. (1992) · Blood · doi:10.1182/blood.v79.9.2364.2364 · Cited by 97
Cytokines and the Koch phenomenon
Rook, G. A. W., & Attiyah, R. A. (1991) · Tubercle · doi:10.1016/0041-3879(91)90019-o · Cited by 98
Plasma tumor necrosis factor soluble receptors in chronic renal failure
Brockhaus, M., Bar‐Khayim, Y., Gurwicz, S., Frensdorff, A., & Haran, N. (1992) · Kidney International · doi:10.1038/ki.1992.332 · Cited by 97
Muenzner, P., Dehio, C., Fujiwara, T., Achtman, M., Meyer, T. F., & Gray‐Owen, S. D. (2000) · Infection and Immunity · doi:10.1128/iai.68.6.3601-3607.2000 · Cited by 97
“TNF-a is one of the principal mediators of endotoxic shock (4, 26, 39, 40 ).”
BackgroundGeist, L. J., Monick, M. M., Stinski, M. F., & Hunninghake, G. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116995 · Cited by 94
“TNF inhibit the lethal effects of endotoxin in animal models (7).”
BackgroundTumour Necrosis Factor Alpha (TNF‐α) and Interleukin 6 in a Zymosan‐Induced Shock Model
von Asmuth, E. J., Maessen, J. G., van der Linden, J., & Buurman, W. A. (1990) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1990.tb02925.x · Cited by 95
Paradoxical effects of tumour necrosis factor in experimental ovarian cancer
Malik, S., Griffin, D., Fiers, W. C., & Balkwill, F. R. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440529 · Cited by 97
Yoshida, T., Abe, K., Ikeda, T., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.08.012 · Cited by 96
Deree, J., Martins, J. O., Melbostad, H. S., et al. (2008) · Clinics · doi:10.1590/s1807-59322008000300006 · Cited by 96
Cytokine-binding proteins: stimulating antagonists
Klein, B., & Brailly, H. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80161-8 · Cited by 96
Catecholamines increase monocyte TNF receptors and inhibit TNF through β2-adrenoreceptor activation
Guirao, X., Kumar, A., Katz, J. A., Smith, M. G., Lin, E., Keogh, C., Calvano, S. E., & Lowry, S. F. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1203 · Cited by 96
Self-citationStrategies for blocking the systemic effects of cytokines in the sepsis syndrome
Christman, J. W., Holden, E. P., & Blackwell, T. S. (1995) · Critical Care Medicine · doi:10.1097/00003246-199505000-00027 · Cited by 96
Erlotinib protects against LPS-induced Endotoxicity because TLR4 needs EGFR to signal
De, S., Zhou, H., DeSantis, D., Croniger, C. M., Li, X., & Stark, G. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511794112 · Cited by 96
“Treatment of LPS-injected animals with neutralizing antibodies against proinflammatory cytokines resulted in improved outcomes (37, 38).”
BackgroundPatil, R. H., Babu, R. L., Kumar, M. N., et al. (2015) · Inflammation · doi:10.1007/s10753-015-0232-z · Cited by 95
Marriott, H. M., Hellewell, P. G., Cross, S. S., Ince, P. G., Whyte, M. K. B., & Dockrell, D. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6480 · Cited by 96
“Nevertheless, excessive TNF- production, via its effects on neutrophil activation, contributes to lung injury in a variety of diseases (44–46) and may worsen disease outcome during septic shock (47, 48).”
BackgroundInfection of Neonatal Mice with Sindbis Virus Results in a Systemic Inflammatory Response Syndrome
Klimstra, W. B., Ryman, K. D., Bernard, K. A., Nguyen, K. B., Biron, C. A., & Johnston, R. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10387-10398.1999 · Cited by 95
“In addition, the levels of TNF-a present in sera of TR339- and TRSB-infected mice are similar to those reported in SIRS models such as fatal LPS treatment of adult mice and with fatal gram-negative sepsis (4, 25, 50, 60).”
BackgroundResult
Metadata
- Authors
- Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A.
- Affiliations
- Cornell University (US)
- Rockefeller University (US)
- Venue
- Nature
- Published
- 1987-12
- Volume
- 330
- Issue
- 6149
- Pages
- 662-664
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2038434279
- Cited by
- 2,448
- References
- 1
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 19 · 2023: 17 · 2022: 13 · 2021: 24 · 2020: 24 · 2019: 32 · 2018: 31 · 2017: 24 · 2016: 40 · 2015: 33 · 2014: 44 · 2013: 43 · 2012: 46
- FWCI
- 95.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TNF-α, septic shock, bacteremia, Escherichia coli, passive immunization, neutralizing monoclonal antibodies, F(ab')2 fragments, endotoxic shock, organ failure, renal failure, respiratory failure, stress hormones, baboons, sepsis treatment
- MeSH terms
- Animals, Antibodies, Monoclonal, Blood Pressure, Cardiac Output, Catecholamines, Glucagon, Immunization, Passive, Immunologic Techniques, Leukocyte Count, Papio, Shock, Septic, Tumor Necrosis Factor-alpha, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review